Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01531049
Other study ID # EETTMK:99/2011
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received February 3, 2012
Last updated June 2, 2017
Start date May 2012
Est. completion date September 2, 2016

Study information

Verified date June 2017
Source University of Oulu
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the efficacy and effectiveness of varenicline and nicotine patch combined with motivational interview technique in smoking cessation of young adults over 12 months follow-up.


Description:

Most teenage smokers are still smoking when they become adults confirming that stopping of smoking at young age is difficult although majority of young smokers want to quit. Young smokers experience many relapses partly due to the lack of appropriate and available cessation services. The discomfort experienced during cessation attempts is likely to be negatively associated with cessation success. Quitting of smoking is by the far most important procedure in preventing COPD progression. In Finland, 18-35% of young adults smoke, the variability being associated at least with socioeconomic background, education and geographical area. Our recent studies on male military draftees have shown that smoking is much more frequent in Northern than Southern Finland. However young men want to quit and accept new smoking restrictions. Very few studies are available on quitting attempts or counselling, pharmacotherapy and/or their combinations in young adults who want to quit.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date September 2, 2016
Est. primary completion date December 31, 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 26 Years
Eligibility Inclusion Criteria:

- healthy daily smokers

- a daily smoker has smoked at least 1cig/day every day during last month and has smoked at least 100 cig ever

- a nonsmoker has smoked less than 50 cig ever,and has not smoked at all during last month

- motivated to quit smoking and ready to 12 months follow-up

- minor allergy or mild asthma without regular medication is allowed

Exclusion Criteria:

- any chronic disease with daily medication

- known allergy to study medications(varenicline, nicotine patch,nicotine gum)

- any substance and/or alcohol abuse

- drop-outs are counted as current smokers

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
varenicline
days 1.-3 0,5mgx1/day, days 4.-7 0,5mgx2/day, day 8 to the 12weeks 1mgx2 /day
Nicotine cutaneous patch 15mg/16h
One patch for 16hours/day and duration of 8 weeks.
Nicotine cutaneous patch 10mg/16h
One patch 16hours/day and duration of 8 weeks
Other:
Placebo cutaneous patch
No active medication.O ne patch 16hours and duration for 8 weeks

Locations

Country Name City State
Finland Lapland Central Hospital, Lapland Hospital District Rovaniemi

Sponsors (3)

Lead Sponsor Collaborator
Tuula Toljamo Helsinki University, University of Oulu

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary The abstinence rate 3 months follow-up
Secondary The saliva cotinine verified abstinence rate 3 months follow-up
Secondary The abstinence rate 1, 6 and 12 months follow-up
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04617444 - The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function N/A
Completed NCT02796391 - Facilitating Smoking Cessation With Reduced Nicotine Cigarettes Phase 2
Completed NCT03397511 - Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City N/A
Not yet recruiting NCT05188287 - A Culturally Tailored Smartphone Application for African American Smokers N/A
Recruiting NCT05264428 - The Effect of Honey on Lessening the Withdrawal Symptoms N/A
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT04133064 - Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study N/A
Completed NCT03187730 - Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants Phase 4
Completed NCT03474783 - To Explore the Factors Affecting the Effectiveness of Smoking Cessation N/A
Completed NCT04635358 - Feasibility Study of Smoking Cessation for the Staff of a Hospital Center N/A
Terminated NCT03670264 - BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation N/A
Not yet recruiting NCT06307496 - VIDeOS for Smoking Cessation N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02905656 - Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit N/A
Completed NCT02997657 - Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial N/A
Completed NCT02239770 - Pharmacokinetics of Nicotine Film in Smokers N/A
Completed NCT02562521 - A Smoking Cessation Intervention for Yale Dining Employees Phase 4
Recruiting NCT02422914 - Benefits of Tobacco Free Cigarette N/A